Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells

Elena A. Federzoni, Peter J. M. Valk, Bruce E. Torbett, Torsten Haferlach, Bob Löwenberg, Martin F. Fey, Mario P. Tschan

Blood (2012) 119 (21): 4963–4970.

https://doi.org/10.1182/blood-2011-09-378117

Published: 2012

Includes: Supplemental data

Journal Articles

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Edo Vellenga, Wim van Putten, Gert J. Ossenkoppele, Leo F. Verdonck, Matthias Theobald, Jan J. Cornelissen, Peter C. Huijgens, Johan Maertens, Alois Gratwohl, Ron Schaafsma, Urs Schanz, Carlos Graux, Harry C. Schouten, Augustin Ferrant, Mario Bargetzi, Martin F. Fey, Bob Löwenberg, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), and Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Blood (2011) 118 (23): 6037–6042.

https://doi.org/10.1182/blood-2011-07-370247

Published: 2011

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Blood (2011) 118 (21): 159.

https://doi.org/10.1182/blood.V118.21.159.159

Published: 2011

Journal Articles

Inhibition of Key Autophagy Genes in Primary AML Patients and Their Functional Role in Neutrophil Differentiation of APL Cells

Mario P. Tschan, PhD, Daniel Brigger, M.Sc., Anna M. Schläfli, M.Sc., Martin F. Fey, MD

Blood (2011) 118 (21): 2456.

https://doi.org/10.1182/blood.V118.21.2456.2456

Published: 2011

Journal Articles

Linking the Glycolytic Enzyme HK3 to Neutrophil Differentiation of APL Cells Via PU.1

Elena A. Federzoni, M.Sc., Peter Valk, Bob Löwenberg, MD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2011) 118 (21): 2425.

https://doi.org/10.1182/blood.V118.21.2425.2425

Published: 2011

Journal Articles

Involvement of Death-Associated Protein Kinases In DNA Damage Responses of B-ALL Cells.

Magali Humbert, PhD,, Michaela Medova, PhD,, Barbara Geering, PhD, Wieslawa Blank-Liss, Hans-Uwe Simon, MD, PhD, Martin F. Fey, MD, Yitzhak Zimmer, PhD, Mario P. Tschan, PhD

Blood (2010) 116 (21): 3369.

https://doi.org/10.1182/blood.V116.21.3369.3369

Published: 2010

Journal Articles

The Autophagy Gene ULK1 Plays a Role In AML Differentiation and Is Negatively Regulated by the Oncogenic MicroRNA 106a

Mario P. Tschan, PhD, Melanie Jost, MD, Jasmin Batliner, PhD, Student, Martin F. Fey, MD

Blood (2010) 116 (21): 503.

https://doi.org/10.1182/blood.V116.21.503.503

Published: 2010

Journal Articles

Activation of Myeloid Differentiation-Associated Autophagy In Combination with ATRA-Therapy Enhances Neutrophil Differentiation of AML Cells.

Magali Humbert, PhD, Student, Adiran Britschgi, PhD, Hans-Uwe Simon, MD, PhD, Andreas H. Tobler, MD, Shida Yousefi, PhD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2010) 116 (21): 1046.

https://doi.org/10.1182/blood.V116.21.1046.1046

Published: 2010

Journal Articles

NDRG1 Expression Is Inhibited in AML and Its Knockdown Attenuates Neutrophil Differentiation.

Mario P. Tschan, PhD, Deborah Shan, Judith Laedrach, Marianne Eyholzer, Elisabeth Oppliger Leibundgut, PhD, Gabriela Baerlocher, MD, Andreas Tobler, MD, Deborah Stroka, PhD, Martin F. Fey, MD

Blood (2008) 112 (11): 927.

https://doi.org/10.1182/blood.V112.11.927.927

Published: 2008

Journal Articles

Blocking the Autophagy Gene 5 (ATG5) Impairs ATRA-Induced Myeloid Differentiation, and ATG5 Is Downregulated in AML

Adrian Britschgi, MSc, Shida Yousefi, PhD, Judith Laedrach, Deborah Shan, Hans-Uwe Simon, MD, PhD, Andreas Tobler, MD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 309.

https://doi.org/10.1182/blood.V112.11.309.309

Published: 2008

Journal Articles

Mir-29c and Mir-424 Are Novel Myeloid Differentiation-Associated MicroRNAs in Acute Promyelocytic Leukemia.

Jasmin Batliner, MSc, Mathias Jenal, MSc, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 3346.

https://doi.org/10.1182/blood.V112.11.3346.3346

Published: 2008

Journal Articles

The Anti-Apoptotic Gene BCL2A1 Is Transcriptionally Regulated by PU.1

Mathias Jenal, MSc, Venkateshwar A. Reddy, PhD, Judith Laedrach, Deborah Shan, Andreas Tobler, MD, Bruce E. Torbett, PhD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 3579.

https://doi.org/10.1182/blood.V112.11.3579.3579

Published: 2008

Journal Articles

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

Adrian Britschgi, MSc, Hans-Uwe Simon, MD, PhD, Andreas Tobler, MD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 2628.

https://doi.org/10.1182/blood.V112.11.2628.2628

Published: 2008

Journal Articles

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression

Beatrice U. Mueller, Thomas Pabst, José Fos, Vibor Petkovic, Martin F. Fey, Norio Asou, Ulrich Buergi, Daniel G. Tenen

Blood (2006) 107 (8): 3330–3338.

https://doi.org/10.1182/blood-2005-07-3068

Published: 2006

Includes: Supplemental data

Journal Articles

Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2).

Mattia Rizzi, MD, Christian Britschgi, MD, Mario P. Tschan, PhD, Tobias J. Grob, MD, PhD, Barbara Huegli, Nicolas Leupin, MD, Beatrice U. Mueller, MD, Andrew Ziemiecki, PhD, Bruce E. Torbett, PhD, Martin F. Fey, MD, Andreas Tobler, MD

Blood (2005) 106 (11): 1348.

https://doi.org/10.1182/blood.V106.11.1348.1348

Published: 2005

Journal Articles

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

Bronno van der Holt, Bob Löwenberg, Alan K. Burnett, Wolfgang U. Knauf, John Shepherd, Pier Paolo Piccaluga, Gert J. Ossenkoppele, Gregor E. G. Verhoef, Augustin Ferrant, Michael Crump, Dominik Selleslag, Matthias Theobald, Martin F. Fey, Edo Vellenga, Margaret Dugan, Pieter Sonneveld, on behalf of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and the United Kingdom Medical Research Council (MRC)

Blood (2005) 106 (8): 2646–2654.

https://doi.org/10.1182/blood-2005-04-1395

Published: 2005

Journal Articles

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, Julian Schardt, Myriam Eyer, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2005) 106 (4): 1369–1375.

https://doi.org/10.1182/blood-2004-11-4392

Published: 2005

Journal Articles

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2004) 104 (11): 3388.

https://doi.org/10.1182/blood.V104.11.3388.3388

Published: 2004

Journal Articles

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

Blood (2004) 103 (12): 4416–4423.

https://doi.org/10.1182/blood-2003-10-3411

Published: 2004

Journal Articles

A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)

Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, Dominique Mühlematter, Martine Jotterand, Celine Besse, Nicolas Leupin, Daniel Ratschiller, Jeanette Papp, Gina Kearsey, Stefan Aebi, Hans Graber, Rolf Jaggi, Jean-Marc Lüthi, Sandrine Meyer-Monard, Mark Lathrop, Andreas Tobler, Martin F. Fey

Blood (2002) 100 (5): 1787–1794.

https://doi.org/10.1182/blood.V100.5.1787.h81702001787_1787_1794

Published: 2002

NARROW

PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Inhibition of Key Autophagy Genes in Primary AML Patients and Their Functional Role in Neutrophil Differentiation of APL Cells

Linking the Glycolytic Enzyme HK3 to Neutrophil Differentiation of APL Cells Via PU.1

Involvement of Death-Associated Protein Kinases In DNA Damage Responses of B-ALL Cells.

The Autophagy Gene ULK1 Plays a Role In AML Differentiation and Is Negatively Regulated by the Oncogenic MicroRNA 106a

Activation of Myeloid Differentiation-Associated Autophagy In Combination with ATRA-Therapy Enhances Neutrophil Differentiation of AML Cells.

NDRG1 Expression Is Inhibited in AML and Its Knockdown Attenuates Neutrophil Differentiation.

Blocking the Autophagy Gene 5 (ATG5) Impairs ATRA-Induced Myeloid Differentiation, and ATG5 Is Downregulated in AML

Mir-29c and Mir-424 Are Novel Myeloid Differentiation-Associated MicroRNAs in Acute Promyelocytic Leukemia.

The Anti-Apoptotic Gene BCL2A1 Is Transcriptionally Regulated by PU.1

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression

Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2).

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only